Mode
Text Size
Log in / Sign up
Phase 3 N=90 Randomized Triple-blind Treatment

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

Pain · Postoperative Depression

Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Change in Pain Scores — 1.45; 1 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Ketamine (Drug); Placebo Comparator (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
NYU Langone Health
Primary completion
Apr 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Pain Scores
1.45; 1
SECONDARY
Length of Stay During Hospitalization
1.3; 1.2

Summary

This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.

Eligibility Criteria

Inclusion Criteria

  • Adults, >18 years, 65 years of age
  • Pregnant or breastfeeding
  • Does not speak or understand English (the study forms used are copy-righted in English)
  • Cognitively impairment (by history) or clinical signs of altered mental status
  • History of misuse or abuse of ketamine
  • History of chest pain or chest pain in the PACU
  • Use of a medication that interferes with metabolism of ketamine within the last 24 hours
  • A diagnosis of schizophrenia and/ or a history of chronic antipsychotic medication use
  • History of head trauma
  • History of intracranial mass or hemorrhage
  • History of stroke
  • History of cardiac arrhythmia
  • Subject for whom ketamine is contraindicated
  • Unwillingness to give informed consent according to HIC guidelines
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02452060). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search